FDA Inspection
David A. Plager, M.D.David A. Plager, M.D. – FDA Inspection, Jul 27, 2016
Record Details
This FDA Inspection record concerns David A. Plager, M.D., with an inspection on July 27, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- David A. Plager, M.D.
- Inspection Date
- July 27, 2016
- Product Type
- Drugs
View Company Profile
ID · d7ce3e7d-7de9-40ed-ba05-22837c84e838
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 978040
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.66Changes in research
Full citation text and observation details available on the Dashboard.
Other FDA inspections of David A. Plager, M.D.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 18, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 1, 2013 | VAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
Other documents for David A. Plager, M.D.
- FDA Inspection 1070035 - 2018-09-18
- FDA Inspection 838571 - 2013-07-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.